Malignant Neoplasm of Unknown Primary — Trials

Malignant Neoplasm of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,263 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,163
Recruiting: 2,261
Ph III recruiting: 268
Growth YoY: +12.8%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,897)

clinicaltrialsPublishedShowing 851–900 of 2,265 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07508852	68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer	recruiting	Phase 1 / Phase 2	30	Peking University First HospitalOTHER	1	Jun 18, 2026	clinicaltrials
NCT07624487	Aumolertinib Combined With Phased Chemotherapy for EGFR L858R Lung Adenocarcinoma	recruiting	Phase 2	50	Taipei Medical University HospitalOTHER	1	Jun 18, 2026	clinicaltrials